About Innova Biosciences
Innova Biosciences is a Healthcare company based in Cambridge (United Kingdom) founded in 2002, and was acquired by Abcam in November 2019. Antibody labeling and bioconjugation kits are developed and marketed. Innova Biosciences has raised $196.74 thousand across 3 funding rounds from investors including Abcam and SYGNIS. The company has 1,587 employees. The company was acqui-hired. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Proteomics. Its legal entity is ABCAM LIMITED.
Company details
Innova Biosciences is engaged in the development, manufacturing and marketing of antibody labeling and bioconjugation kits. The company offers a variety of antibody labeling kits (enzyme , fluorescent protein, biotinstreptavidin, tandem, and fluorescent dye tags). In addition, it offers antibody purification kits, gold conjugation kits, immunogen kits, maleimide activated labels, substrates and stabilizers, phosphate detection assays, and affinity resins. On September 19, 2016, the company launched a new product AbPure Magnetic Purification system- the system is based on Protein A Magnetic Beads, with high affinity for IgG molecules thus allowing to purify small quantities of antibody from complex mixtures.
- Headquarters Cambridge, United Kingdom
- Employees 1,587
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website innovabiosciences.com
- Social LinkedIn X Facebook
- Acquired by Abcam (Nov 2019)
- Legal Name Abcam Limited
- Date of Incorporation 12 Feb, 1998
- Jurisdiction CAMBRIDGE, UNITED KINGDOM
Funding Insights of Innova Biosciences
Innova Biosciences has successfully raised a total of $196.74K across 3 strategic funding rounds. The most recent funding activity was a Grant round of $337.28 thousand completed in May 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $196,740
- Total Rounds 3
- Last Round Grant — $337,281
- First Round $196,740
(Jun 2007)
All 3 funding rounds of Innova Biosciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2012 | $337,281 | Grant | – | – | – |
| Feb 2009 | $647,897 | Grant | – | – | – |
| Jun 2007 | $196,740 | Seed | – | – | – |
2 investors in total: 2 institutional.
Investors in Innova Biosciences
Innova Biosciences has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Abcam and SYGNIS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Biological reagents and antibodies are developed for life science research. | 1998 | abcam.com | Cambridge, United Kingdom | |
SYGNIS provides molecular biology reagents for research and laboratory applications. | 1997 | sygnis.com | Madrid, Spain |
Investor details for Innova Biosciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Innova Biosciences
Web traffic of Innova Biosciences
Websites that share an audience with Innova Biosciences (innovabiosciences.com).
Websites whose visitors overlap most with Innova Biosciences. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| trevigen.com | 100% | View details | |||
| epitomics.com | 94% | View details | |||
| everestbiotech.com | 94% | 1.6K | #10,518,665 | View details | |
| abingdonhealth.com | 88% | 9.5K | #2,244,705 | View details | |
| phosphosolutions.com | 87% | View details | |||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 25 similar websites and full traffic analytics for Innova Biosciences
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 25 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Innova Biosciences (Life Sciences Platforms & Tools) in United Kingdom, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | |||
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Innova Biosciences
Complete news archive for Innova Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Innova Biosciences
Innova Biosciences was founded in 2002 and raised its 1st funding round 5 years after it was founded.
Innova Biosciences is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.
Innova Biosciences is a funded company, having raised a total of $196.74K across 3 funding rounds to date. The company's 1st funding round was a Seed of $196.74K, raised on Jun 2007.
Innova Biosciences has 1,587 employees.
Annual revenue of Innova Biosciences is $333.72M as on Dec 31, 2020.
Innova Biosciences is engaged in the development, manufacturing and marketing of antibody labeling and bioconjugation kits. The company offers a variety of antibody labeling kits (enzyme , fluorescent protein, biotinstreptavidin, tandem, and fluorescent dye tags). In addition, it offers antibody purification kits, gold conjugation kits, immunogen kits, maleimide activated labels, substrates and stabilizers, phosphate detection assays, and affinity resins. On September 19, 2016, the company launched a new product AbPure Magnetic Purification system- the system is based on Protein A Magnetic Beads, with high affinity for IgG molecules thus allowing to purify small quantities of antibody from complex mixtures.
Innova Biosciences operates through Abcam Limited.
Yes. Innova Biosciences was acquired by Abcam in November 2019.